<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">LGLbpXh9YT4mXwfN387sgLc</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2012001500012</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(12)09900600012</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2012005000104</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigo Original</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Bioimped&#226;ncia transtor&#225;cica comparada &#224; resson&#226;ncia magn&#233;tica na avalia&#231;&#227;o do d&#233;bito card&#237;aco</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Villacorta Junior</surname>
            <given-names>Humberto</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Villacorta</surname>
            <given-names>Aline Sterque</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Amador</surname>
            <given-names>Fernanda</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hadlich</surname>
            <given-names>Marcelo</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Albuquerque</surname>
            <given-names>Denilson Campos de</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Azevedo</surname>
            <given-names>Clerio Francisco</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Rio de Janeiro</named-content>
          <named-content content-type="state">RJ</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal Fluminense</institution>
        <country country="BR">Brasil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">Rio de Janeiro</named-content>
          <named-content content-type="state">RJ</named-content>
        </addr-line>
        <institution content-type="orgname">Instituto DO'r de Pesquisa e Ensino</institution>
        <country country="BR">Brasil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>12</month>
        <year>2012</year>
      </pub-date>
      <volume>99</volume>
      <issue>6</issue>
      <fpage>1149</fpage>
      <lpage>1155</lpage>
      <history>
        <date date-type="received">
          <day>06</day>
          <month>03</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>07</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>17</day>
          <month>03</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: A resson&#226;ncia magn&#233;tica card&#237;aca &#233; considerada o m&#233;todo padr&#227;o-ouro para o c&#225;lculo de volumes card&#237;acos. A bioimped&#226;ncia transtor&#225;cica card&#237;aca avalia o d&#233;bito card&#237;aco. N&#227;o h&#225; trabalhos que validem essa medida comparada &#224; resson&#226;ncia. OBJETIVO: Avaliar o desempenho da bioimped&#226;ncia transtor&#225;cica card&#237;aca no c&#225;lculo do d&#233;bito card&#237;aco, &#237;ndice card&#237;aco e volume sist&#243;lico, utilizando a resson&#226;ncia como padr&#227;o-ouro. M&#201;TODOS: Avaliados 31 pacientes, com m&#233;dia de idade de 56,7 &#177; 18 anos, sendo 18 (58%) do sexo masculino. Foram exclu&#237;dos os pacientes cuja indica&#231;&#227;o para a resson&#226;ncia magn&#233;tica card&#237;aca inclu&#237;a avalia&#231;&#227;o sob estresse farmacol&#243;gico. A correla&#231;&#227;o entre os m&#233;todos foi avaliada pelo coeficiente de Pearson, e a dispers&#227;o das diferen&#231;as absolutas em rela&#231;&#227;o &#224; m&#233;dia foi demonstrada pelo m&#233;todo de Bland-Altman. A concord&#226;ncia entre os m&#233;todos foi realizada pelo coeficiente de correla&#231;&#227;o intraclasses. RESULTADOS: A m&#233;dia do d&#233;bito card&#237;aco pela bioimped&#226;ncia transtor&#225;cica card&#237;aca e pela resson&#226;ncia foi, respectivamente, 5,16 &#177; 0,9 e 5,13 &#177; 0,9 L/min. Observou-se boa correla&#231;&#227;o entre os m&#233;todos para o d&#233;bito card&#237;aco (r = 0,79; p = 0,0001), &#237;ndice card&#237;aco (r = 0,74; p = 0,0001) e volume sist&#243;lico (r = 0,88; p = 0,0001). A avalia&#231;&#227;o pelo gr&#225;fico de Bland-Altman mostrou pequena dispers&#227;o das diferen&#231;as em rela&#231;&#227;o &#224; m&#233;dia, com baixa amplitude dos intervalos de concord&#226;ncia. Houve boa concord&#226;ncia entre os dois m&#233;todos quando avaliados pelo coeficiente de correla&#231;&#227;o intraclasses, com coeficientes para d&#233;bito card&#237;aco, &#237;ndice card&#237;aco e volume sist&#243;lico de 0,78, 0,73 e 0,88, respectivamente (p &lt; 0,0001 para todas as compara&#231;&#245;es). CONCLUS&#195;O: A bioimped&#226;ncia transtor&#225;cica card&#237;aca mostrou-se acurada no c&#225;lculo do d&#233;bito card&#237;aco quando comparada &#224; resson&#226;ncia magn&#233;tica card&#237;aca.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Insufici&#234;ncia Card&#237;aca</kwd>
        <kwd>Imped&#226;ncia El&#233;trica</kwd>
        <kwd>D&#233;bito Card&#237;aca</kwd>
        <kwd>D&#233;bito Card&#237;aco</kwd>
        <kwd>Espectroscopia de Resson&#226;ncia Magn&#233;tica</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>16</day>
        <month>11</month>
        <year>2012</year>
      </pub-date>
    </article-meta>
  </front>
  <body><p>Bioimped&#226;ncia transtor&#225;cica comparada &#224; resson&#226;ncia magn&#233;tica na avalia&#231;&#227;o do d&#233;bito card&#237;aco</p><p><bold>Humberto Villacorta Junior<sup>I</sup>; Aline Sterque Villacorta<sup>I</sup>; Fernanda Amador<sup>II</sup>; Marcelo Hadlich<sup>II</sup>; Denilson Campos de Albuquerque<sup>II</sup>; Clerio Francisco Azevedo<sup>II</sup></bold></p><p><sup>I</sup>Universidade Federal Fluminense, Rio de Janeiro, RJ &#150; Brasil </p><p><sup>II</sup>Instituto DO'r de Pesquisa e Ensino, Rio de Janeiro, RJ &#150; Brasil</p><p><xref ref-type="corresp" rid="nt">Correspond&#234;ncia</xref></p><p><bold>RESUMO</bold></p><p><bold>FUNDAMENTO: </bold> A resson&#226;ncia magn&#233;tica card&#237;aca &#233; considerada o m&#233;todo padr&#227;o-ouro para o c&#225;lculo de volumes card&#237;acos. A bioimped&#226;ncia transtor&#225;cica card&#237;aca avalia o d&#233;bito card&#237;aco. N&#227;o h&#225; trabalhos que validem essa medida comparada &#224; resson&#226;ncia. </p><p><bold>OBJETIVO: </bold> Avaliar o desempenho da bioimped&#226;ncia transtor&#225;cica card&#237;aca no c&#225;lculo do d&#233;bito card&#237;aco, &#237;ndice card&#237;aco e volume sist&#243;lico, utilizando a resson&#226;ncia como padr&#227;o-ouro. </p><p><bold>M&#201;TODOS: </bold> Avaliados 31 pacientes, com m&#233;dia de idade de 56,7 &#177; 18 anos, sendo 18 (58%) do sexo masculino. Foram exclu&#237;dos os pacientes cuja indica&#231;&#227;o para a resson&#226;ncia magn&#233;tica card&#237;aca inclu&#237;a avalia&#231;&#227;o sob estresse farmacol&#243;gico. A correla&#231;&#227;o entre os m&#233;todos foi avaliada pelo coeficiente de Pearson, e a dispers&#227;o das diferen&#231;as absolutas em rela&#231;&#227;o &#224; m&#233;dia foi demonstrada pelo m&#233;todo de Bland-Altman. A concord&#226;ncia entre os m&#233;todos foi realizada pelo coeficiente de correla&#231;&#227;o intraclasses. </p><p><bold>RESULTADOS: </bold> A m&#233;dia do d&#233;bito card&#237;aco pela bioimped&#226;ncia transtor&#225;cica card&#237;aca e pela resson&#226;ncia foi, respectivamente, 5,16 &#177; 0,9 e 5,13 &#177; 0,9 L/min. Observou-se boa correla&#231;&#227;o entre os m&#233;todos para o d&#233;bito card&#237;aco (r = 0,79; p = 0,0001), &#237;ndice card&#237;aco (r = 0,74; p = 0,0001) e volume sist&#243;lico (r = 0,88; p = 0,0001). A avalia&#231;&#227;o pelo gr&#225;fico de Bland-Altman mostrou pequena dispers&#227;o das diferen&#231;as em rela&#231;&#227;o &#224; m&#233;dia, com baixa amplitude dos intervalos de concord&#226;ncia. Houve boa concord&#226;ncia entre os dois m&#233;todos quando avaliados pelo coeficiente de correla&#231;&#227;o intraclasses, com coeficientes para d&#233;bito card&#237;aco, &#237;ndice card&#237;aco e volume sist&#243;lico de 0,78, 0,73 e 0,88, respectivamente (p &lt; 0,0001 para todas as compara&#231;&#245;es). </p><p><bold>CONCLUS&#195;O: </bold> A bioimped&#226;ncia transtor&#225;cica card&#237;aca mostrou-se acurada no c&#225;lculo do d&#233;bito card&#237;aco quando comparada &#224; resson&#226;ncia magn&#233;tica card&#237;aca. </p><p><bold>Palavras-chave: </bold> Insufici&#234;ncia Card&#237;aca; Imped&#226;ncia El&#233;trica; D&#233;bito Card&#237;aca; D&#233;bito Card&#237;aco; Espectroscopia de Resson&#226;ncia Magn&#233;tica.</p><p><bold>Introdu&#231;&#227;o</bold></p><p>A insufici&#234;ncia card&#237;aca (IC) &#233; uma desordem associada &#224; ativa&#231;&#227;o neuro-hormonal, que, em &#250;ltima an&#225;lise, resulta em altera&#231;&#245;es hemodin&#226;micas, como redu&#231;&#227;o do d&#233;bito card&#237;aco (DC), aumento das press&#245;es de enchimento do ventr&#237;culo esquerdo e aumento da resist&#234;ncia vascular sist&#234;mica (RVS)<sup>1,2</sup>. Al&#233;m disso, a maioria das medica&#231;&#245;es utilizadas para o tratamento da IC, tanto cr&#244;nica como aguda, apresenta efeitos sobre a hemodin&#226;mica cardiovascular. Medidas hemodin&#226;micas espec&#237;ficas, como DC, RVS e press&#227;o de capilar pulmonar geralmente s&#227;o obtidas apenas em pacientes cr&#237;ticos, em grande parte por causa do risco, desconforto e custo de procedimentos invasivos como a monitoriza&#231;&#227;o por cateter de Swan-Ganz. No entanto, a medida desses valores poderia ser &#250;til no manuseio de pacientes com IC, mesmo n&#227;o cr&#237;ticos.</p><p>A bioimped&#226;ncia transtor&#225;cica card&#237;aca (BTC) &#233; um m&#233;todo n&#227;o invasivo que permite a estimativa de par&#226;metros hemodin&#226;micos<sup>3-5</sup>. Ela &#233; uma forma de pletismografia que utiliza mudan&#231;as na imped&#226;ncia el&#233;trica tor&#225;cica para estimar mudan&#231;as no volume sangu&#237;neo no interior da aorta e mudan&#231;as no volume de fluido do t&#243;rax. Dessa forma, podem-se estimar par&#226;metros hemodin&#226;micos e o <italic>status</italic> vol&#234;mico. Apesar de a BTC ter sido avaliada em algumas situa&#231;&#245;es cl&#237;nicas<sup>6-9</sup>, h&#225; questionamentos sobre sua acur&#225;cia e utilidade<sup>10</sup>. A resson&#226;ncia magn&#233;tica card&#237;aca (RMC) &#233; considerada padr&#227;o-ouro para o c&#225;lculo de volumes card&#237;acos<sup>11,12</sup> e nenhum estudo anterior comparou os dois m&#233;todos.</p><p>O objetivo desse trabalho foi determinar o desempenho da BTC no c&#225;lculo do DC, utilizando-se a RMC como padr&#227;o-ouro.</p><p><bold>M&#233;todos</bold></p><p>No per&#237;odo de mar&#231;o a junho de 2007, foram inclu&#237;dos 31 pacientes encaminhados por seus m&#233;dicos assistentes para realiza&#231;&#227;o ambulatorial de RMC. A m&#233;dia de idade foi de 56,7 &#177; 18 anos e 18 (58%) eram do sexo masculino. As indica&#231;&#245;es para realiza&#231;&#227;o da RMC foram: 1) Avalia&#231;&#227;o de cardiopatia isqu&#234;mica cr&#244;nica (pr&#233;vio infarto agudo do mioc&#225;rdio (IAM), viabilidade mioc&#225;rdica) em 11 pacientes; 2) Avalia&#231;&#227;o de arritmia (arritmia ventricular, extrass&#237;stoles ventriculares frequentes ao Holter, palpita&#231;&#245;es etc.) em 11 pacientes; 3) Avalia&#231;&#227;o da etiologia de cardiomiopatias em seis pacientes; e 4) Avalia&#231;&#227;o de miocardite aguda/subaguda em tr&#234;s pacientes.</p><p>Por raz&#245;es log&#237;sticas internas, foram inclu&#237;dos pacientes que realizaram RMC em um dia espec&#237;fico da semana. Imediatamente antes da RMC, eram submetidos &#224; avalia&#231;&#227;o pela BTC. Foram exclu&#237;dos pacientes cuja indica&#231;&#227;o de RMC inclu&#237;a avalia&#231;&#227;o sob estresse farmacol&#243;gico.</p><p>O exame de RMC foi realizado em repouso, em aparelho de resson&#226;ncia magn&#233;tica com campo principal de 1,5 tesla (Gyroscan NT Intera, Philips Medical System, Best, The Netherlands). Para fazer a avalia&#231;&#227;o dos par&#226;metros funcionais do ventr&#237;culo esquerdo (VE), foi utilizada uma sequ&#234;ncia de pulsos do tipo gradiente-eco com magnetiza&#231;&#227;o transversal em estado de equil&#237;brio (<italic>steady-statefreeprecession </italic>&#150; SSFP), com os seguintes par&#226;metros: TR 3,1 ms; TE 1,55 ms; &#194;ngulo de inclina&#231;&#227;o: 55&#186;; <italic>FOV</italic> 350-420 mm; matriz: 192 x 192; <italic>ScanPercentage</italic> 70%; <italic>RFOV:</italic> 75%; fases: 24; <italic>WFS</italic>: 0,21 pixels; <italic>NSA</italic> 1, cortes: 8-10; espessura: 8 mm; intervalo 2mm.</p><p>Foram adquiridos, de forma sequencial, oito a 10 cortes do eixo curto do ventr&#237;culo esquerdo cobrindo toda cavidade ventricular, do &#225;pice ao anel mitral. A aquisi&#231;&#227;o de cada corte teve dura&#231;&#227;o de aproximadamente oito segundos (cerca de oito a 12 batimentos card&#237;acos, dependendo da frequ&#234;ncia card&#237;aca), durante os quais o paciente era solicitado a prender a respira&#231;&#227;o.</p><p>Foram calculados quatro par&#226;metros utilizando o m&#233;todo de Simpson: fra&#231;&#227;o de eje&#231;&#227;o (FE), volume diast&#243;lico final (VDF), volume sist&#243;lico final (VSF) e volume sist&#243;lico (VS) de eje&#231;&#227;o. Esses par&#226;metros foram obtidos das imagens de cine-RM da seguinte forma: contorno manual, em <italic>software</italic> espec&#237;fico comercialmente dispon&#237;vel (ViewForum, version 4.2, Philips Medical Systems, Best, The Netherlands), da borda endoc&#225;rdica do VE nas fases diast&#243;lica (maior &#225;rea) e sist&#243;lica (menor &#225;rea) nos 8-10 cortes do eixo curto do VE. O VDF foi medido como a soma dos produtos da &#225;rea de cada corte na fase diast&#243;lica vezes a espessura do corte. O VSF foi calculado de forma semelhante, mas utilizando para o c&#225;lculo a fase sist&#243;lica de cada corte. O VS foi calculado como: VS = VDF&#150;VSF; e a FE como: FE = (VS/VDF) x 100. Os volumes VDF, VSF e VS foram ent&#227;o normalizados para a &#225;rea de superf&#237;cie corporal, gerando os par&#226;metros IVDF, IVSF e IVS. Finalmente, o d&#233;bito card&#237;aco foi calculado como: DC = VS x FC.</p><p>A BTC foi realizada pelo aparelho Bio Z Dx Diagnostics, Cardiodynamics, San Diego, CA, Estados Unidos. Foram utilizados quatro pares de eletrodos posicionados no pesco&#231;o e t&#243;rax, conectados ao aparelho port&#225;til, do tamanho proporcional a um eletrocardi&#243;grafo. Uma corrente alternada de baixa frequ&#234;ncia e alta amplitude &#233; gerada pelos quatro sensores externos e os eletrodos internos captam as mudan&#231;as instant&#226;neas de voltagem. De acordo com a lei de Ohm, quando uma corrente constante &#233; aplicada no t&#243;rax, as mudan&#231;as de voltagem s&#227;o diretamente proporcionais a mudan&#231;as da imped&#226;ncia. A imped&#226;ncia total do t&#243;rax, denominada imped&#226;ncia basal, &#233; o somat&#243;rio da imped&#226;ncia de todos os componentes tor&#225;cicos (tecido adiposo, cora&#231;&#227;o, pulm&#227;o, m&#250;sculo esquel&#233;tico, tecido vascular, ossos e ar). As varia&#231;&#245;es em rela&#231;&#227;o &#224; imped&#226;ncia basal ocorrem em virtude das modifica&#231;&#245;es no volume pulmonar com a respira&#231;&#227;o e mudan&#231;as no volume sangu&#237;neo no interior de grandes vasos durante s&#237;stole e di&#225;stole. O componente respirat&#243;rio &#233; filtrado e removido da an&#225;lise do aparelho, deixando apenas as varia&#231;&#245;es decorrentes das modifica&#231;&#245;es sangu&#237;neas no interior da aorta, permitindo os c&#225;lculos hemodin&#226;micos. V&#225;rios par&#226;metros s&#227;o fornecidos pelo aparelho, como DC, &#237;ndice card&#237;aco VS, resist&#234;ncia arterial perif&#233;rica, par&#226;metros de contratilidade e conte&#250;do de fluido tor&#225;cico. No presente trabalho, foram analisados somente o DC, &#237;ndice card&#237;aco e VS.</p><p>Os dados foram apresentados como m&#233;dia e desvio-padr&#227;o, pois apresentavam distribui&#231;&#227;o normal. A compara&#231;&#227;o entre as m&#233;dias foi feita pelo Teste <italic>t</italic> de Student. A correla&#231;&#227;o entre os m&#233;todos foi avaliada pelo coeficiente de Pearson e a dispers&#227;o das diferen&#231;as absolutas em rela&#231;&#227;o &#224; m&#233;dia foi demonstrada pelo m&#233;todo de Bland-Altman. A concord&#226;ncia entre os m&#233;todos foi realizada pelo coeficiente de correla&#231;&#227;o intraclasses (ICC). O crit&#233;rio de determina&#231;&#227;o de signific&#226;ncia adotado foi o n&#237;vel de 5% e a an&#225;lise foi feita pelo <italic>software</italic> SAS<sup>&#174;</sup><italic>System</italic>, vers&#227;o 6.04.</p><p><bold>Resultados</bold></p><p>A <xref ref-type="table" rid="tab01">Tabela 1</xref> mostra as caracter&#237;sticas basais da popula&#231;&#227;o. A fra&#231;&#227;o de eje&#231;&#227;o m&#233;dia, calculada pela RMC foi 62 &#177; 17%. Do total de 31 pacientes, nove apresentavam disfun&#231;&#227;o sist&#243;lica global pela RMC e 12 apresentavam altera&#231;&#245;es da contratilidade regional. Quatro pacientes apresentavam hipertrofia conc&#234;ntrica do VE. O DC na popula&#231;&#227;o como um todo, calculado pela BTC e RMC, foi, respectivamente, 5,16 &#177; 0,9 e 5,13 &#177; 0,9 (p = 0,76). Houve boa correla&#231;&#227;o entre os m&#233;todos quanto ao DC, &#237;ndice card&#237;aco e VS, como observado nas <xref ref-type="fig" rid="fig1_3">Figuras 1 a 3</xref>. A avalia&#231;&#227;o pelo gr&#225;fico de Bland-Altman mostrou pequena dispers&#227;o das diferen&#231;as em rela&#231;&#227;o &#224; m&#233;dia, com baixa amplitude dos intervalos de concord&#226;ncia (<xref ref-type="fig" rid="fig04">Figura 4</xref>). Houve boa concord&#226;ncia entre os dois m&#233;todos quando avaliados pelo ICC, conforme mostrado na <xref ref-type="table" rid="tab02">Tabela 2</xref>.</p><p content-type="asset"><table-wrap id="tab01"><graphic xlink:href="1678-4170-abc-99-06-1149-00104-gt01.jpg"/></table-wrap></p><p content-type="asset"><fig id="fig04"><graphic xlink:href="1678-4170-abc-99-06-1149-00104-gf01.jpg"/></fig></p><p><fig id="fig1_3"><graphic xlink:href="1678-4170-abc-99-06-1149-00104-gf02.jpg"/></fig>&#13;
&#160;&#13;
</p><p><fn id="fig02"><p><graphic xlink:href="1678-4170-abc-99-06-1149-00104-e01.jpg"/></p></fn></p>&#13;
&#160;&#13;
&#160;&#13;
<p><fn id="fig03"><p><graphic xlink:href="1678-4170-abc-99-06-1149-00104-e02.jpg"/></p></fn></p>&#13;
&#13;
 <table-wrap id="tab02"><graphic xlink:href="1678-4170-abc-99-06-1149-00104-gt02.jpg"/></table-wrap>   <p><bold>Discuss&#227;o</bold></p> <p>No presente trabalho, demonstramos que a BTC apresentou bom desempenho no c&#225;lculo do DC, &#237;ndice card&#237;aco e VS, usando-se a RMC como padr&#227;o-ouro. Esse &#233; o &#250;nico estudo realizado em uma popula&#231;&#227;o est&#225;vel, ambulatorial, com a finalidade de avaliar a acur&#225;cia da BTC na medida do DC.</p> <p>Utilizamos a RMC como m&#233;todo de refer&#234;ncia. Sua utilidade em estimar o d&#233;bito card&#237;aco foi confirmada por v&#225;rias t&#233;cnicas, em estudos experimentais e cl&#237;nicos, mostrando bom desempenho<sup>13-16</sup>.</p> <p>A acur&#225;cia da medida de d&#233;bito card&#237;aco usando-se a nova gera&#231;&#227;o de aparelhos de BTC j&#225; foi realizada por m&#233;todos invasivos, em cen&#225;rios de terapia intensiva<sup>3</sup>, p&#243;s-operat&#243;rio de cirurgia de revasculariza&#231;&#227;o mioc&#225;rdica<sup>5</sup> e em laborat&#243;rio de hemodin&#226;mica em pacientes com hipertens&#227;o pulmonar<sup>4</sup>. Em todos esses estudos, a BTC apresentou um bom desempenho no c&#225;lculo do d&#233;bito card&#237;aco, com correla&#231;&#227;o moderada com c&#225;lculos feitos pelos m&#233;todos de Fick ou termodilui&#231;&#227;o<sup>3-5</sup>. Em nosso estudo, confirmamos esses achados em pacientes menos graves, ambulatoriais, em que a medida invasiva dos par&#226;metros hemodin&#226;micos n&#227;o seria &#233;tica, lan&#231;ando-se m&#227;o de um m&#233;todo n&#227;o invasivo, por&#233;m acurado, como a RMC.</p> <p>A aplica&#231;&#227;o cl&#237;nica da BTC foi avaliada em pacientes com dispneia aguda na sala de emerg&#234;ncia<sup>6,7</sup>. A BTC fez com que o m&#233;dico mudasse seu diagn&#243;stico em 13% dos casos e mudasse as medica&#231;&#245;es em 39% dos pacientes<sup>6</sup>. Em outro estudo, foi &#250;til em diferenciar dispneia de origem card&#237;aca <italic>versus</italic> n&#227;o card&#237;aca<sup>7</sup>. Esses trabalhos, no entanto, pecam pela falta de grupo controle e pela n&#227;o randomiza&#231;&#227;o, o que dificulta a avalia&#231;&#227;o do desempenho do m&#233;todo na mudan&#231;a de desfechos.</p> <p>Em um estudo ambulatorial &#150; estudo PREDICT &#150; com pacientes portadores de IC que foram recentemente hospitalizados, a BTC realizada de forma seriada foi capaz de identificar pacientes de alto risco para hospitaliza&#231;&#227;o e morte. Tr&#234;s par&#226;metros da BTC foram &#250;teis nessa an&#225;lise &#150; o &#237;ndice de velocidade, o conte&#250;do de fluxo tor&#225;cico indexado e o tempo de eje&#231;&#227;o ventricular esquerdo. N&#227;o h&#225;, no entanto, trabalhos que mostrem que medidas seriadas com BTC possam alterar os desfechos cl&#237;nicos.</p> <p>No &#250;nico estudo randomizado e cego, em pacientes com IC grave, n&#227;o foi poss&#237;vel demonstrar benef&#237;cio cl&#237;nico do m&#233;todo<sup>10</sup>. O estudo BIG<sup>10</sup> inclui um subgrupo do estudo ESCAPE<sup>17</sup>, em que pacientes com IC grave eram hospitalizados para ajustar a medica&#231;&#227;o guiada por par&#226;metros hemodin&#226;micos invasivos. Essa abordagem n&#227;o foi melhor que o ajuste convencional, feito pelo exame cl&#237;nico<sup>17</sup>. No subgrupo submetido &#224; avalia&#231;&#227;o com BTC, observou-se modesta correla&#231;&#227;o do DC medido pela BTC com os par&#226;metros invasivos (r variando entre 0,4 a 0,6 em medidas seriadas). O conte&#250;do de fluido tor&#225;cico calculado pela BTC n&#227;o foi uma medida confi&#225;vel para estimar a press&#227;o encunhada de capilar pulmonar. Al&#233;m disso, diferentemente do estudo PREDICT, a BTC n&#227;o apresentou utilidade progn&#243;stica.</p> <p>No contexto da hipertens&#227;o arterial, um estudo randomizado demonstrou benef&#237;cio da BTC no controle da press&#227;o arterial<sup>9</sup>. A taxa de pacientes com press&#227;o arterial controlada (&lt; 140 x 90 mmHg) ao final do estudo no grupo BTC e controle foi, respectivamente, 77% e 57%. Para press&#227;o arterial &lt; 130 x 85 mmHg, esses valores foram 55% <italic>versus</italic> 27%.</p> <p>Com base nesses estudos, podemos concluir que, embora a BTC possa medir o d&#233;bito card&#237;aco e a resist&#234;ncia perif&#233;rica com moderada acur&#225;cia, n&#227;o h&#225; dados que indiquem mudan&#231;a em desfechos cl&#237;nicos com o m&#233;todo, com poss&#237;vel exce&#231;&#227;o no cen&#225;rio de pacientes com hipertens&#227;o arterial n&#227;o controlada. O m&#233;todo, no entanto, pode ser &#250;til em pesquisas, como em estudos de mecanismos de doen&#231;as e estudos de respostas hemodin&#226;micas a determinados f&#225;rmacos ou interven&#231;&#245;es.</p> <p>Em conclus&#227;o, a avalia&#231;&#227;o do DC pela BTC mostrou-se acurada em pacientes est&#225;veis ambulatoriais, usando-se a RMC como padr&#227;o-ouro.</p> <p><bold>Potencial Conflito de Interesses</bold></p> <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p> <p><bold>Fontes de Financiamento</bold></p> <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p> <p><bold>Vincula&#231;&#227;o Acad&#234;mica</bold></p> <p>N&#227;o h&#225; vincula&#231;&#227;o deste estudo a programas de p&#243;s-gradua&#231;&#227;o.</p>                <p>13. Culham JA, Vince DJ. Cardiac output by MRI imaging: an experimental study comparing right ventricle and left ventricle with thermodilution. Can Assoc Radiol J 1988;39(4):247-9.</p>         <p><fn id="nt" fn-type="corresp"><p>Correspond&#234;ncia:</p><p>Humberto Villacorta Junior </p><p> Rua Visconde de Silva, 154, 402, Humait&#225; </p><p> CEP 22271090, Rio de Janeiro, RJ &#150; Brasil </p><p> E-mail: </p><p><email xlink:href="hvillacorta@cardiol.br">hvillacorta@cardiol.br</email>, </p><p><email xlink:href="huvillacorta@globo.com">huvillacorta@globo.com</email></p></fn></p> <p>Artigo recebido em 06/03/12 </p><p> revisado em 07/03/12 </p><p> aceito em 31/07/12</p></body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999;341(8):577-85.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hormones and hemodynamics in heart failure</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>577</fpage>
          <lpage>85</lpage>
          <issue>8</issue>
          <volume>341</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Schrier</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Abraham</surname>
              <given-names>WT</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2. Bocchi EA, Marcondes-Braga FG, Bacal F, Ferraz AS, Albuquerque D, Rodrigues D, et al. Atualiza&#231;&#227;o da Diretriz Brasileira de Insufici&#234;ncia Card&#237;aca Cr&#244;nica. Arq Bras Cardiol 2012;98(1 supl. 1):1-33.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Atualiza&#231;&#227;o da Diretriz Brasileira de Insufici&#234;ncia Card&#237;aca Cr&#244;nica</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2012</year>
          </date>
          <fpage>1</fpage>
          <lpage>33</lpage>
          <volume>98</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bocchi</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Marcondes-Braga</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>Bacal</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ferraz</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Albuquerque</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3. Marik PE, Pendelton JE, Smith R. A comparison of hemodynamic parameters derived from transthoracic electrical bioimpedance with those parameters obtained by thermodilution and ventricular angiography. Crit Care Med 1997;25(9):1545-50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A comparison of hemodynamic parameters derived from transthoracic electrical bioimpedance with those parameters obtained by thermodilution and ventricular angiography</article-title>
          <source>Crit Care Med</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>1545</fpage>
          <lpage>50</lpage>
          <issue>9</issue>
          <volume>25</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Marik</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Pendelton</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation>4. Yung GL, Fedullo PF, Kinninger K, Johnson W, Channick RN. Comparison of impedance cardiography to direct Fick and thermodilution cardiac output determination in pulmonary arterial hypertension. Cong Heart Fail 2004;10(Suppl 2):7-10.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparison of impedance cardiography to direct Fick and thermodilution cardiac output determination in pulmonary arterial hypertension</article-title>
          <source>Cong Heart Fail</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>7</fpage>
          <lpage>10</lpage>
          <volume>10</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Yung</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Fedullo</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Kinninger</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Channick</surname>
              <given-names>RN</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation>5. Van de Water JM, Miller TW, Vogel RL, Mount BE, Dalton ML. Impedance cardiography: the next vital sign technology? Chest 2003;123(6):2028-33.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Impedance cardiography: the next vital sign technology?</article-title>
          <source>Chest</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>2028</fpage>
          <lpage>33</lpage>
          <issue>6</issue>
          <volume>123</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Van de Water</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Vogel</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Mount</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Dalton</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation>6. Peacock WF, Summers RL, Vogel J, Emerman CE. Impact of impedance cardiography on diagnosis and therapy of emergent dyspnea: the ED-IMPACT trial. Acad Emerg Med 2006;13(4):365-71.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Impact of impedance cardiography on diagnosis and therapy of emergent dyspnea: the ED-IMPACT trial</article-title>
          <source>Acad Emerg Med</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>365</fpage>
          <lpage>71</lpage>
          <issue>4</issue>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Peacock</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Summers</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Vogel</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Emerman</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation>7. Springfield CL, Sebat F, Johnson D, Lengle S, Sebat C. Utility of impedance cardiography to determine cardiac vs. noncardiac cause of dyspnea in the emergency department. Cong Heart Fail 2004;10(Suppl 2):14-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Utility of impedance cardiography to determine cardiac vs: noncardiac cause of dyspnea in the emergency department</article-title>
          <source>Cong Heart Fail</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>14</fpage>
          <lpage>6</lpage>
          <volume>10</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Springfield</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Sebat</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lengle</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sebat</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation>8. Packer M, Abraham WT, Mehra MR, Yancy CW, Lawless CE, Mitchell JE, et al. Prospective Evaluation and Identification of Cardiac Decompensation by ICG Test (PREDICT) Study Investigators and Coordinators. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol. 2006;47(11):2245-52.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prospective Evaluation and Identification of Cardiac Decompensation by ICG Test (PREDICT) Study Investigators and Coordinators: Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>2245</fpage>
          <lpage>52</lpage>
          <issue>11</issue>
          <volume>47</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Packer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Abraham</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Mehra</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Yancy</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Lawless</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation>9. Smith RD, Levy P, Ferrario CM, for the Consideration of Nonivasive Hemodynamic Monitoring to Target Reduction of Blood Pressure Levels Study Group. Value of nonivasive hemodynamics to achieve blood pressure control in hypertensive subjects. Hypertension 2006;47(4):769-75.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Value of nonivasive hemodynamics to achieve blood pressure control in hypertensive subjects</article-title>
          <source>Hypertension</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>769</fpage>
          <lpage>75</lpage>
          <issue>4</issue>
          <volume>47</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ferrario</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation>10. Kamath AS, Drazner MH, Tasissa G, Rogers JG, Stevenson LW, Yancy CW. Correlation of impedance cardiography with invasive hemodynamic measurements in patients with advanced heart failure: the BioImpedance CardioGraphy (BIG) substudy of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) Trial. Am Heart J 2009;158(2):217-23.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Correlation of impedance cardiography with invasive hemodynamic measurements in patients with advanced heart failure: the BioImpedance CardioGraphy (BIG) substudy of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) Trial</article-title>
          <source>Am Heart J</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>217</fpage>
          <lpage>23</lpage>
          <issue>2</issue>
          <volume>158</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kamath</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Drazner</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Tasissa</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rogers</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Stevenson</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>Yancy</surname>
              <given-names>CW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation>11. Azevedo Filho CF, Hadlich M, Petriz JLF, Mendon&#231;a LA, Moll Filho JN, Rochitte CE. Quantification of left ventricular infarcted mass on cardiac magnetic resonance imaging: comparison between planimetry and the semiquantitative visual scoring method. Arq Bras Cardiol 2004;83(2):111-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Quantification of left ventricular infarcted mass on cardiac magnetic resonance imaging: comparison between planimetry and the semiquantitative visual scoring method</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>111</fpage>
          <lpage>7</lpage>
          <issue>2</issue>
          <volume>83</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Azevedo Filho</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Hadlich</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Petriz</surname>
              <given-names>JLF</given-names>
            </name>
            <name>
              <surname>Mendon&#231;a</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Moll Filho</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Rochitte</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation>12. Rochitte CE, Pinto IM, Fernandes JL, Filho CF, Jatene A, Carvalho AC, et al. Grupo de Estudo em Resson&#226;ncia e Tomografia Cardiovascular (GERT) do Departamento de Cardiologia Cl&#237;nica da Sociedade Brasileira de Cardiologia. Cardiovascular magnetic resonance and computed tomography imaging guidelines of the Brazilian Society of Cardiology. Arq Bras Cardiol 2006;87(3):e60-100.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiovascular magnetic resonance and computed tomography imaging guidelines of the Brazilian Society of Cardiology</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>e60</fpage>
          <lpage>100</lpage>
          <issue>3</issue>
          <volume>87</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rochitte</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Pinto</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Fernandes</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Filho</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Jatene</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>14. Hunter GJ, Hamberg LM, Weisskoff RM, Halpern EF, Brady TJ. Measurement of stroke volume and cardiac output within a single breath hold with echo-planar MR imaging. J Magn Reson Imaging 1994;4(1):51-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Measurement of stroke volume and cardiac output within a single breath hold with echo-planar MR imaging</article-title>
          <source>J Magn Reson Imaging</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>51</fpage>
          <lpage>8</lpage>
          <issue>1</issue>
          <volume>4</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hunter</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Hamberg</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Weisskoff</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Halpern</surname>
              <given-names>EF</given-names>
            </name>
            <name>
              <surname>Brady</surname>
              <given-names>TJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>15. Hundley WG, Li HF, Hillis LD, Meshack BM, Lange RA, Willard JE, et al. Quantitation of cardiac output with velocity-encoded, phase-difference magnetic resonance imaging. Am J Cardiol 1995;75(17):1250-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Quantitation of cardiac output with velocity-encoded, phase-difference magnetic resonance imaging</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>1250</fpage>
          <lpage>5</lpage>
          <issue>17</issue>
          <volume>75</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hundley</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>HF</given-names>
            </name>
            <name>
              <surname>Hillis</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Meshack</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Lange</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Willard</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>16. James SH, Wald R, Wintersperger BJ, Jimez-Juan L, Deva D, Crean AM, et al. Accuracy of right and left ventricular functional assessment by short-axis vs axial cine steady-state free-procession magnetic resonance imaging: intrapatient correlation with main pulmonary artery and ascending aorta phase-contrast flow measurement. Can Assoc Radiol J. 2012; May 10 (Epub ahead of print).</mixed-citation>
        <element-citation publication-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>James</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Wald</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wintersperger</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Jimez-Juan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Deva</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Crean</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>17. Binanay C, Califf RM, Hasselblad V, O'Connor CM, Shah MR, Sopko G, et al.. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE Trial. JAMA 2005;294(13):1625-33.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE Trial</article-title>
          <source>JAMA</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>1625</fpage>
          <lpage>33</lpage>
          <issue>13</issue>
          <volume>294</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Binanay</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Califf</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Hasselblad</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>O'Connor</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Sopko</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Transthoracic impedance compared to magnetic resonance imaging in the assessment of cardiac output</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Cardiac magnetic resonance imaging is considered the gold-standard method for the calculation of cardiac volumes. Transthoracic impedance cardiography assesses the cardiac output. No studies validating this measurement, in comparison to that obtained by magnetic resonance imaging, are available. OBJECTIVE: To evaluate the performance of transthoracic impedance cardiography in the calculation of the cardiac output, cardiac index and stroke volume using magnetic resonance imaging as the gold-standard. METHODS: 31 patients with a mean age of 56.7 &#177; 18 years were assessed; of these, 18 (58%) were males. Patients whose indication for magnetic resonance imaging required pharmacologic stress test were excluded. Correlation between methods was assessed using the Pearson's coefficient, and dispersion of absolute differences in relation to the mean was demonstrated using the Bland-Altman's method. Agreement between methods was analyzed using the intraclass correlation coefficient. RESULTS: The mean cardiac output by transthoracic impedance cardiography and by magnetic resonance imaging was 5.16 &#177; 0.9 and 5.13 &#177; 0.9 L/min, respectively. Good agreement between methods was observed for cardiac output (r = 0.79; p = 0.0001), cardiac index (r = 0.74; p = 0.0001) and stroke volume (r = 0.88; p = 0.0001). The analysis by the Bland-Altman plot showed low dispersion of differences in relation to the mean, with a low amplitude of agreement intervals. Good agreement between the two methods was observed when analyzed by the intraclass correlation coefficient, with coefficients for cardiac output, cardiac index and stroke volume of 0.78, 0.73 and 0.88, respectively (p &lt; 0.0001 for all comparisons). CONCLUSION: Transthoracic impedance cardiography proved accurate in the calculation of the cardiac output in comparison to cardiac magnetic resonance imaging.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Heart failure</kwd>
        <kwd>electric impedance</kwd>
        <kwd>cardiac ouput</kwd>
        <kwd>magnetic resonance spectroscopy</kwd>
      </kwd-group>
    </front-stub>
    <body><p><fn id="tx-body2"><label><bold>Transthoracic impedance compared to magnetic resonance imaging in the assessment of cardiac output</bold></label><p><bold>Humberto Villacorta Junior<sup>I</sup>; Aline Sterque Villacorta<sup>I</sup>; Fernanda Amador<sup>II</sup>; Marcelo Hadlich<sup>II</sup>; Denilson Campos de Albuquerque<sup>II</sup>; Clerio Francisco Azevedo<sup>II</sup></bold></p></fn></p><p><sup>I</sup>Universidade Federal Fluminense, Rio de Janeiro, RJ &#150; Brasil</p><p><sup>II</sup>Instituto DO'r de Pesquisa e Ensino, Rio de Janeiro, RJ &#150; Brasil</p><p>Mailing Address</p><p><bold>RESUMO</bold></p><p><bold>BACKGROUND: </bold> Cardiac magnetic resonance imaging is considered the gold-standard method for the calculation of cardiac volumes. Transthoracic impedance cardiography assesses the cardiac output. No studies validating this measurement, in comparison to that obtained by magnetic resonance imaging, are available.</p><p><bold> OBJECTIVE: </bold>To evaluate the performance of transthoracic impedance cardiography in the calculation of the cardiac output, cardiac index and stroke volume using magnetic resonance imaging as the gold-standard.</p><p><bold> METHODS: </bold>31 patients with a mean age of 56.7 &#177; 18 years were assessed; of these, 18 (58%) were males. Patients whose indication for magnetic resonance imaging required pharmacologic stress test were excluded. Correlation between methods was assessed using the Pearson's coefficient, and dispersion of absolute differences in relation to the mean was demonstrated using the Bland-Altman's method. Agreement between methods was analyzed using the intraclass correlation coefficient.</p><p><bold> RESULTS: </bold> The mean cardiac output by transthoracic impedance cardiography and by magnetic resonance imaging was 5.16 &#177; 0.9 and 5.13 &#177; 0.9 L/min, respectively. Good agreement between methods was observed for cardiac output (r = 0.79; p = 0.0001), cardiac index (r = 0.74; p = 0.0001) and stroke volume (r = 0.88; p = 0.0001). The analysis by the Bland-Altman plot showed low dispersion of differences in relation to the mean, with a low amplitude of agreement intervals. Good agreement between the two methods was observed when analyzed by the intraclass correlation coefficient, with coefficients for cardiac output, cardiac index and stroke volume of 0.78, 0.73 and 0.88, respectively (p &lt; 0.0001 for all comparisons).</p><p><bold> CONCLUSION: </bold> Transthoracic impedance cardiography proved accurate in the calculation of the cardiac output in comparison to cardiac magnetic resonance imaging. </p><p><bold>Keywords: </bold> Heart failure; electric impedance; cardiac ouput; magnetic resonance spectroscopy.</p><p><bold>Introduction</bold></p><p>Heart failure (HF) is a disorder associated with neurohormonal activation, which ultimately results in hemodynamic changes such as decreased cardiac output (CO), increased left ventricular filling pressures and increased systemic vascular resistance (SVR)<sup>1,2</sup>. In addition, most of the medications used for the treatment of both chronic and acute HF have effects on the cardiovascular hemodynamics. Specific hemodynamic measurements such as CO, SVR, and pulmonary capillary pressure are usually obtained only in critically ill patients due, to a great extent, to the risk, discomfort and costs of invasive procedures such as Swan-Ganz catheter monitoring. However, these measurements could be useful in the management of patients with HF, even those not critically ill.</p><p>Transthoracic impedance cardiography (TIC) is a noninvasive method that allows the estimate of hemodynamic parameters<sup>3-5</sup>. It is a type of pletismography that uses the changes in the thoracic electric impedance to estimate changes in the blood volume within the aorta and changes in the thoracic fluid volume. Thus, hemodynamic parameters and the volemic status can be estimated. Although TIC has been evaluated in some clinical situations<sup>6-9</sup>, some questions remain on its accuracy and usefulness<sup>10</sup>. Cardiac magnetic resonance imaging (CMRI) is considered the gold-standard for the calculation of cardiac volumes<sup>11,12</sup>, and no previous study comparing the two methods has ever been conducted.</p><p>The objective of the present study is to determine the performance of TIC in the calculation of the CO using CMRI as the gold-standard.</p><p><bold>Methods</bold></p><p>From March to June 2007, 31 patients who had been referred by their physicians for ambulatory CMRI were included in this study. Their mean age was 56.7 &#177; 18 years and 18 (58%) were males. Indications for CMRI were the following: 1) assessment of chronic ischemic heart disease (previous myocardial infarction, myocardial viability) in 11 patients; 2) assessment of arrhythmia (ventricular arrhythmia, frequent ventricular extrasystoles on Holter, palpitations, etc) in 11 patients; 3) assessment of the etiology of cardiomyopathies in six patients; and 4) assessment of acute/subacute myocarditis in three patients.</p><p>For internal logistic reasons, patients undergoing CMRI in a specific day of the week were included. Immediately before CMRI, they were assessed by TIC. Patients whose indication for CMRI included pharmacological stress test were excluded.</p><p>CMRI was performed with the patient at rest using an MRI scanner with a main field of 1.5 tesla (Gyroscan NT Intera, Philips Medical System, Best, The Netherlands).: For the assessment of the functional parameters of the left ventricle (LV) a gradient-echo pulse sequence with steady-state free precession &#150; (SSFP) transverse magnetization was used with the following parameters: TR 3.1 ms; TE 1.55 ms; inclination angle: 55&#186;; FOV 350-420 mm; matrix: 192 x 192; scan percentage 70%; RFOV: 75%; phases: 24; WFS: 0,21 pixels; NSA 1, views: 8-10; thickness: 8 mm; interval 2mm.</p><p>Eight to 10 views of the left ventricular short axis were sequentially acquired, covering the whole ventricular cavity from the apex to the mitral ring. Acquisition of each view took approximately eight seconds (from eight to 12 heart beats, depending on the heart rate), during which the patients were asked to hold their breath.</p><p>Four parameters were calculated using the Simpson's method: ejection fraction (EF); end-diastolic volume (EDV); end-systolic volume (ESV); and stroke volume (SV). These parameters were obtained from cine-MRI images as follows: manual contour, in a specific software commercially available (ViewForum, version 4.2, Philips Medical Systems, Best, The Netherlands), of the LV endocardial border in the diastolic (larger area) and systolic (smaller area) phases in the 8-10 views of the LV short axis. EDV was measured as the sum of the products of the area of each view in the diastolic phase multiplied by the view thickness. ESV was calculated similarly, but using the systolic phase of each view for the calculation. SV was calculated as: SV = EDV&#150;ESV; and the EF as: EF = (SV/EDV) x 100. EDV, ESV and VS were then normalized for the body surface area, thus generating the parameters IEDV, IESV and ISV. Finally, the cardiac output was calculated as: CO = SV x HR.</p><p>TIC was performed in a Bio Z Dx Diagnostics device (Cardiodynamics, San Diego, CA, USA). Four pairs of electrodes positioned on the neck and thorax were used; they were connected to a portable device the size of an electrocardiograph. A low-frequency high-amplitude alternating current is generated by the four external sensors and the internal electrodes capture the instant voltage changes. According to Ohm's law, when a steady current is applied to the thorax, the voltage changes are directly proportional to the impedance changes. The total thoracic impedance, named baseline impedance, is the sum of the impedance of all thoracic components (adipose tissue, heart, lung, skeletal muscle, vascular tissue, bones and air). Variations in relation to the baseline impedance occur because of the changes in the pulmonary volume with breathing and changes in blood volume within large vessels during systole and diastole. The respiratory component is filtered and excluded from the device analysis, leaving only the variations resulting from blood changes within the aorta, thus permitting hemodynamic calculations. Several parameters such as CO, cardiac index (CI), SV, peripheral arterial resistance, contractility parameters and thoracic fluid content are provided by the device. In the present study, only CO, CI and SV were analyzed.</p><p>Data were expressed as means and standard deviation, because they were normally distributed. Comparison between means was made using Student's <italic>t</italic> test. Correlation between methods was assessed using the Pearson's coefficient, and dispersion of absolute differences in relation to the mean was demonstrated using the Bland-Altman method. Agreement between methods was made using the intraclass correlation coefficient (ICC). The significance level was set at 5% and the analysis was made using the SAS<sup>&#174;</sup> System software, version 6.04.</p><p><bold>Results</bold></p><p>The baseline population characteristics are shown in <xref ref-type="table" rid="en_0212tab01-body2">Table 1</xref>. The mean ejection fraction, as calculated by CMRI, was 62 &#177; 17%. Of the 31 patients, nine showed global systolic dysfunction on CMRI, and 12 showed regional contractility abnormalities. Four patients showed LV concentric hypertrophy. CO in the population as a whole, as calculated by TIC and CMRI, was 5.16 &#177; 0.9 and 5.13 &#177; 0.9 (p = 0.76), respectively. There was a good correlation between the methods as regards CO, CI and SV, as shown in <xref ref-type="fig" rid="en212fig1_3-body2">Figures 1 to 3</xref>. The Bland-Altman plot showed small dispersion of differences in relation to the mean, with low amplitude of agreement intervals (<xref ref-type="fig" rid="en_0212fig04-body2">Figure 4</xref>). There was good agreement between the two methods when assessed by ICC, as shown in <xref ref-type="table" rid="tab02-body2">Table 2</xref>.</p><p content-type="asset"><table-wrap id="en_0212tab01-body2"><graphic xlink:href="1678-4170-abc-99-06-1149-00104-gt01-en.jpg"/></table-wrap></p><p content-type="asset"><fig id="en_0212fig04-body2"><graphic xlink:href="1678-4170-abc-99-06-1149-00104-gf01-en.jpg"/></fig></p><p><fig id="en212fig1_3-body2"><graphic xlink:href="1678-4170-abc-99-06-1149-00104-gf02-en.jpg"/></fig>&#13;
&#160;&#13;
</p><p><fn id="en_0212fig02-body2"><p><graphic xlink:href="1678-4170-abc-99-06-1149-00104-e01-en.jpg"/></p></fn></p>&#13;
&#160;&#13;
&#160;&#13;
<p><fn id="en_0212fig03-body2"><p><graphic xlink:href="1678-4170-abc-99-06-1149-00104-e02-en.jpg"/></p></fn></p>&#13;
&#13;
 <table-wrap id="tab02-body2"><graphic xlink:href="1678-4170-abc-99-06-1149-00104-gt02-en.jpg"/></table-wrap>   <p><bold>Discussion</bold></p> <p>In the present study, we showed that TIC had a good performance in the calculation of CO, CI and SV, using CMRI as the gold-standard. This is the only study carried out in a stable outpatient population with the objective of evaluating the accuracy of TIC in the measurement of CO.</p> <p>We used CMRI as a reference method. Its usefulness in estimating the cardiac output has been confirmed by various techniques in both experimental and clinical studies, showing good performance<sup>13-16</sup>.</p> <p>The accuracy of cardiac output measurements using the new generation of TIC devices has already been analyzed using invasive methods in intensive care environments<sup>3</sup>, postoperative period of coronary artery bypass grafting<sup>5</sup>, and in hemodynamics laboratory in patients with pulmonary hypertension<sup>4</sup>. In all these studies, TIC showed good performance in the calculation of cardiac output, with moderate correlation with calculations made by the Fick or termodilution methods<sup>3-5</sup>. In our study, we confirmed these findings in less severely ill outpatients in whom invasive measurement of hemodynamic parameters would not the ethical, so we used CMRI, a noninvasive but accurate method.</p> <p>The clinical application of TIC has been assessed in patients with acute dyspnea in the emergency department<sup>6,7</sup>. TIC made physicians change patients' diagnosis in 13% of the cases, and medications in 39% of the patients<sup>6</sup>. In another study, it was useful to differentiate cardiac form noncardiac dyspnea<sup>7</sup>. However, these studies are limited by the lack of a control group and by non-randomization, which makes it difficult to evaluate the ability of the method in changing outcomes.</p> <p>In an outpatient study &#150; the PREDICT study &#150; in recently hospitalized patients with HF, serial TIC was able to identify patients at a high risk for hospitalization and death. Three TIC parameters were useful in this analysis: velocity index, thoracic flow content index, and left ventricular ejection time. However, there is no study available demonstrating that serial TIC measurements could change clinical outcomes.</p> <p>In the only randomized blind study in patients with severe HF, no clinical benefit of the method could be demonstrated<sup>10</sup>. The BIG study<sup>10</sup> includes a subgroup of the ESCAPE study<sup>17</sup> in which patients with severe HF were hospitalized for medication adjustments guided by invasive hemodynamic parameters. This approach did not prove superior to the conventional adjustment based on clinical assessment<sup>17</sup>. In the subgroup undergoing TIC assessment, a modest correlation of CO as measured by TIC was observed in relation to invasive parameters (r ranging between 0.4 and 0.6 in serial measurements). The thoracic fluid content as calculated by TIC was not a reliable measurement to estimate the pulmonary capillary wedge pressure. In addition, unlike in the PREDICT study, TIC did not prove useful to establish the prognosis.</p> <p>In the context of arterial hypertension, a randomized study demonstrated that TIC was beneficial in the control of blood pressure<sup>9</sup>. The rate of patients with controlled blood pressure (&lt; 140 x 90 mmHg) by the end of the study in the groups TIC and control was 77% and 57%, respectively. For blood pressure &lt; 130 x 85 mmHg, these values were 55% versus 27%.</p> <p>Based on these studies, we can conclude that, although TIC may measure cardiac output and peripheral resistance with moderate accuracy, there are no data indicating that the method results in changes in clinical outcomes, with a possible exception in patients with uncontrolled arterial hypertension. However, the method may be useful in research, such as in studies on the mechanisms of diseases and on hemodynamic responses to determined drugs or interventions.</p> <p>In conclusion, the assessment of CO by TIC proved accurate in stable outpatients, using CMRI as the gold-standard.</p> <p><bold> Potential Conflict of Interest</bold></p> <p>No potential conflict of interest relevant to this article was reported.</p> <p><bold>Sources of Funding</bold></p> <p>There were no external funding sources for this study.</p> <p><bold>Study Association</bold></p> <p>This study is not associated with any post-graduation program.</p>   <p><bold>References</bold></p>             <p>13. Culham JA, Vince DJ. Cardiac output by MRI imaging: an experimental study comparing right ventricle and left ventricle with thermodilution. Can Assoc Radiol J 1988;39(4):247-9.</p>    </body>
  </sub-article>
</article>
